Continuous Glucose Monitoring Device Market Size, Share, Trends, Industry Analysis Report: By Component Type (Transmitters & Receivers, Sensors, and Insulin Pumps), Connectivity, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and

The continuous glucose monitoring device market size is expected to reach USD 10.15 billion by 2034, according to a new study by Polaris Market Research. The report “Continuous Glucose Monitoring Device Market Size, Share, Trends, Industry Analysis Report: By Component Type (Transmitters & Receivers, Sensors, and Insulin Pumps), Connectivity, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The continuous glucose monitoring device market consists of medical devices that track glucose levels in real time, offering an alternative to traditional fingerstick testing for individuals suffering from diabetes. These devices use a small sensor placed under the skin to measure glucose in interstitial fluid, transmitting data to a receiver or smart device for continuous monitoring. The market is experiencing significant growth due to the rising global prevalence of diabetes, increasing demand for minimally invasive glucose monitoring solutions, and technological advancements such as AI integration and improved sensor accuracy. The continuous glucose monitoring device market opportunities lie in the expansion of over-the-counter CGM devices, growing adoption in emerging markets, and increasing integration with digital health platforms. Key trends shaping the market include the development of non-invasive CGM systems, regulatory approvals for advanced sensors, and enhanced reimbursement policies driving higher adoption rates.

Continuous Glucose Monitoring Device Market Report Highlights:

By component type, the sensors segment dominates the continuous glucose monitoring device market share due to frequent sensor replacements and continuous advancements in sensor accuracy and wear duration. The segment is also experiencing the highest growth, driven by increasing adoption of real-time glucose monitoring solutions.

By connectivity, the Bluetooth segment dominates the market due to its widespread compatibility with smartphones and other smart devices, enabling seamless data transmission. However, the 4G connectivity segment is witnessing faster growth as it allows real-time remote monitoring, particularly benefiting telemedicine applications.

The homecare diagnostics segment, by end use, holds the largest share, as CGM devices are increasingly preferred for self-monitoring and at-home diabetes management. The segment is also growing rapidly due to the rising demand for convenient, real-time glucose monitoring without frequent hospital visits.

North America holds the largest share of the continuous glucose monitoring device market revenue due to the high prevalence of diabetes, strong reimbursement policies, and widespread adoption of advanced CGM technologies. Asia Pacific is the fastest-growing region, driven by increasing diabetes cases, expanding healthcare infrastructure, and rising awareness of CGM devices.

Several companies are actively contributing to advancements in diabetes management. Dexcom, Inc. is renowned for its innovative CGM systems, offering real-time glucose monitoring solutions. Abbott Laboratories has developed the FreeStyle Libre system, providing users with a sensor-based approach to glucose tracking. Medtronic plc integrates CGM technology with insulin pump systems, enhancing comprehensive diabetes care.

Polaris Market Research has segmented the continuous glucose monitoring device market report on the basis of component type, connectivity, end use, and region:

By Component Type Outlook (Revenue – USD Billion, 2020–2034)

Transmitters & Receivers

Sensors

Insulin Pumps

By Connectivity Outlook (Revenue – USD Billion, 2020–2034)

Bluetooth

4G

By End Use Outlook (Revenue – USD Billion, 2020–2034)

Hospitals

Homecare Diagnostics

Others

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America